Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) was $57.83 for the day, down -3.98% from the previous closing price of $60.23. In other words, the price has decreased by -$3.98 from its previous closing price. On the day, 0.91 million shares were traded. RYTM stock price reached its highest trading level at $59.16 during the session, while it also had its lowest trading level at $54.93.
Ratios:
Our analysis of RYTM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.08 and its Current Ratio is at 3.24. In the meantime, Its Debt-to-Equity ratio is 11.81 whereas as Long-Term Debt/Eq ratio is at 11.74.
On January 02, 2025, Jefferies started tracking the stock assigning a Buy rating and target price of $80.Jefferies initiated its Buy rating on January 02, 2025, with a $80 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 08 ’25 when Cramer Pamela J. sold 20,760 shares for $60.14 per share. The transaction valued at 1,248,490 led to the insider holds 19,209 shares of the business.
Mazabraud Yann sold 17,750 shares of RYTM for $1,082,497 on Apr 08 ’25. The EVP, Head of International now owns 22,620 shares after completing the transaction at $60.99 per share. On Apr 08 ’25, another insider, PAMELA CRAMER, who serves as the Officer of the company, bought 20,760 shares for $54.96 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RYTM now has a Market Capitalization of 3656226560 and an Enterprise Value of 2904356864. For the stock, the TTM Price-to-Sale (P/S) ratio is 28.10 while its Price-to-Book (P/B) ratio in mrq is 166.05. Its current Enterprise Value per Revenue stands at 22.32 whereas that against EBITDA is -11.004.
Stock Price History:
The Beta on a monthly basis for RYTM is 2.35, which has changed by 0.43392015 over the last 52 weeks, in comparison to a change of 0.028231144 over the same period for the S&P500. Over the past 52 weeks, RYTM has reached a high of $68.58, while it has fallen to a 52-week low of $35.17. The 50-Day Moving Average of the stock is 5.82%, while the 200-Day Moving Average is calculated to be 9.90%.
Shares Statistics:
RYTM traded an average of 632.27K shares per day over the past three months and 1293520 shares per day over the past ten days. A total of 62.39M shares are outstanding, with a floating share count of 56.93M. Insiders hold about 9.96% of the company’s shares, while institutions hold 95.05% stake in the company. Shares short for RYTM as of 1741910400 were 4710022 with a Short Ratio of 7.36, compared to 1739491200 on 5410357. Therefore, it implies a Short% of Shares Outstanding of 4710022 and a Short% of Float of 11.1.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
